RBP4 and Insulin resistance: RBP4 also activates antigen-presenting cells, leading to adipose tissue inflammation and systemic insulin resistance (Schiborn et al., 2022), and the muscle-adipose tissue crosstalk mediated by RBP4 exacerbates metabolic dysfunction.